Arif Bilal

Chief Tech Ops OfficerSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Jun 25, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.9M
Net Open-Market Flow
-$1.9M
Transactions
10
8 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2024Sell(S)4K$163.23$636K17K
Jun 24, 2024Sell(S)1K$163.83$173K22K
Jun 24, 2024Sell(S)700$166.10$116K21K
Jun 24, 2024Sell(S)224$167.13$37K21K
Jun 24, 2024Tax withholding(F)2K$164.64$387K29K
Jun 24, 2024Sell(S)6K$162.31$906K24K
Jun 24, 2024Sell(S)300$164.61$49K22K
Jun 21, 2024Option exercise(M)6K31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 21, 2024Option exercise(M)6K$00
Jun 21, 2024Grant(A)6K$06K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-077518) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.